Get the Stockscreener App
30.22
2.61%
0.77
After Hours:
30.22
Progyny Inc stock is traded at $30.22, with a volume of 913.74K.
It is up +2.61% in the last 24 hours and up +20.30% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$29.45
Open:
$29.69
24h Volume:
913.74K
Relative Volume:
0.62
Market Cap:
$2.37B
Revenue:
$1.29B
Net Income/Loss:
$67.69M
P/E Ratio:
39.24
EPS:
0.7701
Net Cash Flow:
$184.42M
1W Performance:
+10.37%
1M Performance:
+20.30%
6M Performance:
+17.40%
1Y Performance:
+42.28%
1-Day Range:
$29.51
$30.32
1-Week Range:
$27.25
$30.32
52-Week Range:
$16.10
$30.32
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
30.22 | 2.26B | 1.29B | 67.69M | 184.42M | 0.7701 |
UNH
Unitedhealth Group Inc
|
425.36 | 377.45B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
104.72 | 131.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
417.89 | 83.98B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
287.77 | 72.93B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
396.75 | 47.69B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
PGNYProgyny Inc Volatility & Greeks - Finviz
Does Progyny’s (PGNY) Index Exit Quietly Recast Its Long‑Term Competitive Positioning? - simplywall.st
Progyny, Inc.(NasdaqGS: PGNY) dropped from Russell 2000 Dynamic Index - marketscreener.com
Progyny stock hits 52-week high at 28.76 USD - Investing.com
Progyny stock hits 52-week high at 28.76 USD By Investing.com - Investing.com Canada
Meridian Small Cap Growth Fund's Progyny Inc(PGNY) Holding History - GuruFocus
Price to sales forward of Progyny, Inc. – NASDAQ:PGNY - TradingView
Price to book forward of Progyny, Inc. – BX:PGNY - TradingView
Price to sales forward of Progyny, Inc. – BX:PGNY - TradingView
Enterprise value to revenue forward of Progyny, Inc. – NASDAQ:PGNY - TradingView
Enterprise value to revenue forward of Progyny, Inc. – BX:PGNY - TradingView
Progyny Inc (PGNY) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Enterprise value to EBIT forward of Progyny, Inc. – NASDAQ:PGNY - TradingView
Enterprise value to EBIT forward of Progyny, Inc. – BX:PGNY - TradingView
Price to earnings forward of Progyny, Inc. – NASDAQ:PGNY - TradingView
Price to earnings forward of Progyny, Inc. – BX:PGNY - TradingView
Progyny Inc (NASDAQ:PGNY) Offers Affordable Growth With Strong Fundamentals - ChartMill
PGNY Stock Price, Quote & Chart - ChartMill
Progyny, Inc. Actuals & Estimates (NASDAQ:PGNY) - TradingView
Progyny, Inc. Actuals & Estimates (BX:PGNY) - TradingView
What Does the Sale of Progyny Shares by the CFO Mean for Investors? - Yahoo Finance
What Does the Sale of Progyny Shares by the CFO Mean for Investors? - The Motley Fool
PGNY Forecast — Price Target — Prediction for 2027 - TradingView
Progyny Inc (PGNY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Progyny, Inc. Stock 12‑Month Price Target Raised to $30.4, Implies 13% Upside - TradingView
Progyny Inc (PGNY) Institutional Confidence - TradingKey
Form 4 Progyny Inc For: 23 June - Investing.com UK
Form 4 Progyny Inc For: 23 June By Investing.com - Investing.com Nigeria
Progyny (PGNY) Chief Product Officer has 819 shares withheld for RSU taxes - Stock Titan
Truist raises Progyny stock price target to $33 on growth outlook - Investing.com
Progyny StockTruist lifts price target ahead of earnings calendar - AD HOC NEWS
Truist Financial Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $33 - Moomoo
Truist Adjusts Price Target on Progyny to $33 From $30, Maintains Buy Rating - marketscreener.com
Progyny Inc (PGNY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Progyny Inc (PGNY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Progyny Inc (PGNY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Progyny Inc (PGNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Progyny Inc (PGNY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Progyny Inc (PGNY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Progyny Inc (PGNY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MERIDIAN GROWTH FUND's Progyny Inc(PGNY) Holding History - GuruFocus
A Look at Progyny Inc (PGNY) After 3.8% Gain -- GF Value $28.04 vs Price $26.63 - GuruFocus
What Progyny (PGNY)'s Governance Shift And $200 Million Buyback Mean For Shareholders - Yahoo Finance
What Progyny (PGNY)'s Supermajority Rollback and US$200 Million Buyback Mean For Shareholders - simplywall.st
Progyny Inc stock (US74340E1038): fertility benefits specialist after recent share price swings - AD HOC NEWS
Progyny (PGNY) Schedule 13G/A Amendment No.4 — Kleiner Perkins shows 0% ownership - Stock Titan
Progyny EVP Allison Swartz sells $45,021 in company stock By Investing.com - Investing.com India
Progyny CFO Mark Livingston sells $64,183 in company stock By Investing.com - Investing.com South Africa
Progyny (NASDAQ:PGNY) EVP Sells $15,022.92 in Stock - MarketBeat
Allison Swartz Sells 1,199 Shares of Progyny (NASDAQ:PGNY) Stock - MarketBeat
Progyny (NASDAQ:PGNY) CFO Sells $64,183.50 in Stock - MarketBeat
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):